Prescription drug · ANDA
Temazepam NDC 43547-613
Temazepam 22.5 mg/1 · Capsule · Oral · Solco Healthcare U.S., LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 43547-613-03 | 43547061303 | 30 CAPSULE in 1 BOTTLE, PLASTIC (43547-613-03)Marketed from Jan 5, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Temazepam
- Generic name (nonproprietary)
- temazepam
- Active ingredients
- Temazepam — 22.5 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Solco Healthcare U.S., LLCNDC labeler code 43547
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 201781
- Marketing start
- Listing expires
- DEA schedule
- CIV
- Other FDA classes
- Benzodiazepines (Chemical structure)
- Identifiers
- Product ID 43547-613_5f04458d-b81c-47f8-ab06-3c47dffc5e4dSPL ID 5f04458d-b81c-47f8-ab06-3c47dffc5e4dSPL set ID 3ce42f0e-821e-4c9a-8f6b-60621628fd4bRxCUI 198241, 198242, 198243, 485489UNII CHB1QD2QSSUPC 0343547614102, 0343547611101, 0343547613037
- Pharmacologic class
- Benzodiazepine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N443547061303followed by a unit qualifier and the quantityPackage 43547-0613-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Temazepam is indicated for the short-term treatment of insomnia (generally 7 to 10 days). For patients with short-term insomnia, instructions in the prescription should indicate that temazepam should be used for short periods of time (7 to 10 days). The clinical trials performed in support of efficacy were 2 weeks in duration with the final formal assessment of sleep latency performed at the end of treatment.
Excerpt only. Read the full label for complete information.
About NDC 43547-613
- What is NDC 43547-613?
- 43547-613 is the product NDC for Temazepam, Temazepam 22.5 mg/1 capsule, listed with the FDA by Solco Healthcare U.S., LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Temazepam.
- What is the active ingredient?
- Temazepam.
- Who is the labeler?
- Solco Healthcare U.S., LLC, NDC labeler code 43547. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Temazepam?
- 83 other product NDCs are listed under this name. See all Temazepam NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Temazepam products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Temazepam | Temazepam 15 mg/1 | CapsuleOral | Amneal Pharmaceuticals of New York LLC | 53746-556 | 53746-0556-0153746-0556-05 |
| Temazepam | Temazepam 30 mg/1 | CapsuleOral | Amneal Pharmaceuticals of New York LLC | 53746-557 | 53746-0557-0153746-0557-05 |
| temazepam | Temazepam 15 mg/1 | CapsuleOral | AvPAK | 50268-779 | 50268-0779-15 |
| temazepam | Temazepam 30 mg/1 | CapsuleOral | AvPAK | 50268-780 | 50268-0780-13 |
| Temazepam | Temazepam 15 mg/1 | CapsuleOral | Preferred Pharmaceuticals Inc. | 68788-8493 | 68788-8493-03 |
| Temazepam | Temazepam 30 mg/1 | CapsuleOral | Advanced Rx Pharmacy of Tennessee, LLC | 80425-0295 | 80425-0295-0180425-0295-0280425-0295-03 |
| Temazepam | Temazepam 7.5 mg/1 | CapsuleOral | Solco Healthcare U.S., LLC | 43547-611 | 43547-0611-10 |
| Temazepam | Temazepam 15 mg/1 | CapsuleOral | Solco Healthcare U.S., LLC | 43547-612 | 43547-0612-1043547-0612-50 |
| Temazepam | Temazepam 30 mg/1 | CapsuleOral | Solco Healthcare U.S., LLC | 43547-614 | 43547-0614-1043547-0614-50 |
| Temazepam | Temazepam 15 mg/1 | CapsuleOral | Advanced Rx Pharmacy of Tennessee, LLC | 80425-0191 | 80425-0191-0180425-0191-02 |
Other NDCs under ANDA 201781
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Temazepam | Temazepam 7.5 mg/1 | CapsuleOral | Solco Healthcare U.S., LLC | 43547-611 |
| Temazepam | Temazepam 15 mg/1 | CapsuleOral | Solco Healthcare U.S., LLC | 43547-612 |
| Temazepam | Temazepam 30 mg/1 | CapsuleOral | Solco Healthcare U.S., LLC | 43547-614 |